Zofran Birth Defects Lawsuit Filed in California

Background on Zofran

Zofran is an anti-nausea medication approved by the FDA for the treatment of chemotherapy and surgery patients. Due to its ability to effectively alleviate nausea and vomiting, the drug is often prescribed off-label as a treatment for morning sickness during pregnancy. As of recently, this off-label use has been linked to numerous birth defects including heart damage, kidney defects, cleft lip or palate, and club foot.

If you took Zofran during pregnancy and your child was born with birth defects, speak to a Zofran Attorney now! You may be entitled to financial compensation.

Zofran Birth Defects Lawsuit Information

On March 6, 2015 Sonya Lampkin filed the first Zofran lawsuit in California against the pharmaceutical giant GlaxoSmithKline (GSK). In the lawsuit Lampkin claims that she was prescribed Zofran off-label during her first trimester of pregnancy without knowing the potential birth defect risks the medication could cause.

When her son was born in 2010, he was diagnosed with the heart condition supraventricular tachycardia (SVT) which causes rapid breathing, shortness of breath and shallow breathing. Due to SVT her son has endured irreversible physical pain and emotional damage. Lampkin states that had she known the Zofran birth defect risks, she would have never taken the medication and her son would have never been diagnosed with SVT.

Lampkin’s claim is the 3rd birth defect lawsuit filed against GSK since February 2015 and one of two cases that has been filed in the state of California.

Zofran Attorney Information

Attorneys are actively seeking cases in which Zofran use during the first trimester of pregnancy caused various birth defects. If your child was born a birth defect after taking Zofran, it’s important that you contact an Attorney who may be able to help you receive financial compensation.

Jared Heath

Jared Heath is the author of The Sound in the Silence. In his role as an SEO content and digital marketing strategist, Jared was directly responsible for managing DrugJustice.com's editorial calendar and published articles on this website from 2015 to 2016. He is now pursuing a new career as a chiropractor.